AKT1 and chondrosarcoma: Our study demonstrates that visfatin enhances PDGF-C production and facilitates EPC angiogenesis in human chondrosarcoma cells by inhibiting miR-1264 production in the PI3K/Akt/mTOR signaling pathway.